Cefotaxime/Clavulanic Acid 30/10 µg ESBL Detection Disc

The Cefotaxime/Clavulanic Acid 30/10 µg Disc is a combination antimicrobial susceptibility test disc used for the phenotypic detection and confirmation of Extended-Spectrum Beta-Lactamase (ESBL) production in appropriate bacterial isolates. Each disc contains 30 µg of cefotaxime and 10 µg of clavulanic acid. It is typically used alongside a Cefotaxime 30 µg disc in a combination disc test. After inoculation on Mueller-Hinton agar, the inhibition zones around the two discs are compared. A significant increase in zone diameter around the cefotaxime/clavulanic acid disc supports the presence of an ESBL-producing organism. The product is intended for professional in-vitro diagnostic use in microbiology, bacteriology, hospital, diagnostic and antimicrobial-resistance laboratories. The 30/10 µg Cefotaxime/Clavulanic Acid format is also recognized as an antimicrobial susceptibility test disc in FDA device records. Key Features - Contains Cefotaxime 30 µg + Clavulanic Acid 10 µg - Designed for phenotypic ESBL confirmation - Suitable for combination disc diffusion testing - Used with a Cefotaxime 30 µg comparison disc - Compatible with Mueller-Hinton agar - Standard antimicrobial susceptibility test format - Typical disc diameter: 6 mm - Clearly coded test disc format - Suitable for clinical microbiology laboratories - Intended for professional in-vitro diagnostic use